APO RESEARCH · REPORT
Viscosupplementation Injection
Viscosupplementation is a medical procedure during which lubricating fluid is injected into a joint. Also called hyaluronic acid injections or hyaluronan injections, viscosupplementation is most commonly used to treat symptoms of symptoms of knee osteoarthritis.
Product & engineering
Understand the product.
Viscosupplementation is a medical procedure during which lubricating fluid is injected into a joint. Also called hyaluronic acid injections or hyaluronan injections, viscosupplementation is most commonly used to treat symptoms of symptoms of knee osteoarthritis.
Viscosupplementation can significantly reduce pain while improving the mobility and function of the joint to make activities of daily living and even athletic or strenuous exercise less painful.
Viscosupplementation is a procedure that involves injecting hyaluronic acid, a gel-like fluid, directly into the joint. Hyaluronic acid is found naturally in the synovial fluid surrounding the joints to reduce friction during movement. The injection goes into effect by lubricating the joint and assisting the synovial fluid to create more cushion. This works to reduce pain and improve the range of motion or the mobility of the joint.
Selected research
Industry Growth & Trends
Global Viscosupplementation Injection Industry Growth and Trends Forecast to 2032
Market perspective
Viscosupplementation is a medical procedure during which lubricating fluid is injected into a joint. Also called hyaluronic acid injections or hyaluronan injections, viscosupplementation is most commonly used to treat symptoms of symptoms of knee osteoarthritis.
Viscosupplementation can significantly reduce pain while improving the mobility and function of the joint to make activities of daily living and even athletic or strenuous exercise less painful.
Viscosupplementation is a procedure that involves injecting hyaluronic acid, a gel-like fluid, directly into the joint. Hyaluronic acid is found naturally in the synovial fluid surrounding the joints to reduce friction during movement. The injection goes into effect by lubricating the joint and assisting the synovial fluid to create more cushion. This works to reduce pain and improve the range of motion or the mobility of the joint.
Read the full market overview
The classification of Viscosupplementation Injection includes Single Injection, Three Injection, Five Injection, and the sales share of Single Injection take about 40%.
Viscosupplementation Injection is widely used in hospitals, clinics and other place. The most proportion of Viscosupplementation Injection used in Hospitals, and the proportion is 55%.
North America is the largest consumption place, with a consumption market share nearly 52%. Following North America, Asia-Pacific is the second largest consumption place with the consumption market share of 28%.
Sanofi, Bioventus, Seikagaku, Anika Therapeutics, LG Chem, Ferring, etc. are the leaders of the industry. Top six company with about 63% market share.
Report Scope
This report provides a structured, data-driven view of the global Viscosupplementation Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Viscosupplementation Injection market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Viscosupplementation Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Viscosupplementation Injection.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Viscosupplementation Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Viscosupplementation Injection Market by Company
Sanofi
Anika Therapeutics
Seikagaku
Zimmer Biomet
Bioventus
Ferring
LG Chem
Freda
Haohai Biological
Shanghai Jingfeng
Viscosupplementation Injection Segment by Type
Single Injection
Three Injection
Five Injection
Viscosupplementation Injection Segment by Application
Hospitals
Clinics
Others
Viscosupplementation Injection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Viscosupplementation Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Viscosupplementation Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Viscosupplementation Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Viscosupplementation Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Viscosupplementation Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Single Injection
- Three Injection
- Five Injection
Applications
- Hospitals
- Clinics
- Others
Companies covered
- Sanofi
- Anika Therapeutics
- Seikagaku
- Zimmer Biomet
- Bioventus
- Ferring
- LG Chem
- Freda
- Haohai Biological
- Shanghai Jingfeng
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Viscosupplementation Injection Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Viscosupplementation Injection Sales Estimates and Forecasts (2021-2032)
- 1.3 Viscosupplementation Injection Market by Type
- 1.3.1 Single Injection
- 1.3.2 Three Injection
- 1.3.3 Five Injection
- 1.4 Global Viscosupplementation Injection Market Size by Type
- 1.4.1 Global Viscosupplementation Injection Market Size Overview by Type (2021-2032)
- 1.4.2 Global Viscosupplementation Injection Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Viscosupplementation Injection Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Viscosupplementation Injection Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Viscosupplementation Injection Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Viscosupplementation Injection Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Viscosupplementation Injection Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Viscosupplementation Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Viscosupplementation Injection Industry Trends
- 2.2 Viscosupplementation Injection Industry Drivers
- 2.3 Viscosupplementation Injection Industry Opportunities and Challenges
- 2.4 Viscosupplementation Injection Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Viscosupplementation Injection Revenue (2021-2026)
- 3.2 Global Top Players by Viscosupplementation Injection Sales (2021-2026)
- 3.3 Global Top Players by Viscosupplementation Injection Price (2021-2026)
- 3.4 Global Viscosupplementation Injection Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Viscosupplementation Injection Major Company Production Sites & Headquarters
- 3.6 Global Viscosupplementation Injection Company, Product Type & Application
- 3.7 Global Viscosupplementation Injection Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Viscosupplementation Injection Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Viscosupplementation Injection Players Market Share by Revenue in 2025
- 3.8.3 2025 Viscosupplementation Injection Tier 1, Tier 2, and Tier 3
4 Viscosupplementation Injection Regional Status and Outlook
- 4.1 Global Viscosupplementation Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Viscosupplementation Injection Historic Market Size by Region
- 4.2.1 Global Viscosupplementation Injection Sales in Volume by Region (2021-2026)
- 4.2.2 Global Viscosupplementation Injection Sales in Value by Region (2021-2026)
- 4.2.3 Global Viscosupplementation Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Viscosupplementation Injection Forecasted Market Size by Region
- 4.3.1 Global Viscosupplementation Injection Sales in Volume by Region (2027-2032)
- 4.3.2 Global Viscosupplementation Injection Sales in Value by Region (2027-2032)
- 4.3.3 Global Viscosupplementation Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Viscosupplementation Injection by Application
- 5.1 Viscosupplementation Injection Market by Application
- 5.1.1 Hospitals
- 5.1.2 Clinics
- 5.1.3 Others
- 5.2 Global Viscosupplementation Injection Market Size by Application
- 5.2.1 Global Viscosupplementation Injection Market Size Overview by Application (2021-2032)
- 5.2.2 Global Viscosupplementation Injection Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Viscosupplementation Injection Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Viscosupplementation Injection Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Viscosupplementation Injection Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Viscosupplementation Injection Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Viscosupplementation Injection Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Viscosupplementation Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Sanofi
- 6.1.1 Sanofi Company Information
- 6.1.2 Sanofi Business Overview
- 6.1.3 Sanofi Viscosupplementation Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Sanofi Viscosupplementation Injection Product Portfolio
- 6.1.5 Sanofi Recent Developments
- 6.2 Anika Therapeutics
- 6.2.1 Anika Therapeutics Company Information
- 6.2.2 Anika Therapeutics Business Overview
- 6.2.3 Anika Therapeutics Viscosupplementation Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Anika Therapeutics Viscosupplementation Injection Product Portfolio
- 6.2.5 Anika Therapeutics Recent Developments
- 6.3 Seikagaku
- 6.3.1 Seikagaku Company Information
- 6.3.2 Seikagaku Business Overview
- 6.3.3 Seikagaku Viscosupplementation Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Seikagaku Viscosupplementation Injection Product Portfolio
- 6.3.5 Seikagaku Recent Developments
- 6.4 Zimmer Biomet
- 6.4.1 Zimmer Biomet Company Information
- 6.4.2 Zimmer Biomet Business Overview
- 6.4.3 Zimmer Biomet Viscosupplementation Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Zimmer Biomet Viscosupplementation Injection Product Portfolio
- 6.4.5 Zimmer Biomet Recent Developments
- 6.5 Bioventus
- 6.5.1 Bioventus Company Information
- 6.5.2 Bioventus Business Overview
- 6.5.3 Bioventus Viscosupplementation Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Bioventus Viscosupplementation Injection Product Portfolio
- 6.5.5 Bioventus Recent Developments
- 6.6 Ferring
- 6.6.1 Ferring Company Information
- 6.6.2 Ferring Business Overview
- 6.6.3 Ferring Viscosupplementation Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Ferring Viscosupplementation Injection Product Portfolio
- 6.6.5 Ferring Recent Developments
- 6.7 LG Chem
- 6.7.1 LG Chem Company Information
- 6.7.2 LG Chem Business Overview
- 6.7.3 LG Chem Viscosupplementation Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 LG Chem Viscosupplementation Injection Product Portfolio
- 6.7.5 LG Chem Recent Developments
- 6.8 Freda
- 6.8.1 Freda Company Information
- 6.8.2 Freda Business Overview
- 6.8.3 Freda Viscosupplementation Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Freda Viscosupplementation Injection Product Portfolio
- 6.8.5 Freda Recent Developments
- 6.9 Haohai Biological
- 6.9.1 Haohai Biological Company Information
- 6.9.2 Haohai Biological Business Overview
- 6.9.3 Haohai Biological Viscosupplementation Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Haohai Biological Viscosupplementation Injection Product Portfolio
- 6.9.5 Haohai Biological Recent Developments
- 6.10 Shanghai Jingfeng
- 6.10.1 Shanghai Jingfeng Company Information
- 6.10.2 Shanghai Jingfeng Business Overview
- 6.10.3 Shanghai Jingfeng Viscosupplementation Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Shanghai Jingfeng Viscosupplementation Injection Product Portfolio
- 6.10.5 Shanghai Jingfeng Recent Developments
7 North America by Country
- 7.1 North America Viscosupplementation Injection Sales by Country
- 7.1.1 North America Viscosupplementation Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Viscosupplementation Injection Sales by Country (2021-2026)
- 7.1.3 North America Viscosupplementation Injection Sales Forecast by Country (2027-2032)
- 7.2 North America Viscosupplementation Injection Market Size by Country
- 7.2.1 North America Viscosupplementation Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Viscosupplementation Injection Market Size by Country (2021-2026)
- 7.2.3 North America Viscosupplementation Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Viscosupplementation Injection Sales by Country
- 8.1.1 Europe Viscosupplementation Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Viscosupplementation Injection Sales by Country (2021-2026)
- 8.1.3 Europe Viscosupplementation Injection Sales Forecast by Country (2027-2032)
- 8.2 Europe Viscosupplementation Injection Market Size by Country
- 8.2.1 Europe Viscosupplementation Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Viscosupplementation Injection Market Size by Country (2021-2026)
- 8.2.3 Europe Viscosupplementation Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Viscosupplementation Injection Sales by Country
- 9.1.1 Asia-Pacific Viscosupplementation Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Viscosupplementation Injection Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Viscosupplementation Injection Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Viscosupplementation Injection Market Size by Country
- 9.2.1 Asia-Pacific Viscosupplementation Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Viscosupplementation Injection Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Viscosupplementation Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Viscosupplementation Injection Sales by Country
- 10.1.1 South America Viscosupplementation Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Viscosupplementation Injection Sales by Country (2021-2026)
- 10.1.3 South America Viscosupplementation Injection Sales Forecast by Country (2027-2032)
- 10.2 South America Viscosupplementation Injection Market Size by Country
- 10.2.1 South America Viscosupplementation Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Viscosupplementation Injection Market Size by Country (2021-2026)
- 10.2.3 South America Viscosupplementation Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Viscosupplementation Injection Sales by Country
- 11.1.1 Middle East and Africa Viscosupplementation Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Viscosupplementation Injection Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Viscosupplementation Injection Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Viscosupplementation Injection Market Size by Country
- 11.2.1 Middle East and Africa Viscosupplementation Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Viscosupplementation Injection Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Viscosupplementation Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Viscosupplementation Injection Value Chain Analysis
- 12.1.1 Viscosupplementation Injection Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Viscosupplementation Injection Production Mode & Process
- 12.2 Viscosupplementation Injection Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Viscosupplementation Injection Distributors
- 12.2.3 Viscosupplementation Injection Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst